Showing results (141-150 of 149) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of Personalized Medicine|April 30, 2021
Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal MelanomatosisAlicia Baumgartner, Natalia Stepien, Lisa Mayr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2020
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma SubgroupChristine Pirker, Agnes Bilecz, Michael Grusch, et al.Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.Blood|June 29, 2012
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentFrancesco Passamonti, Jürgen Thiele, Francois Girodon, et al.Journal of Experimental & Clinical Cancer Research : CR|May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade gliomaLisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.Cell Reports. Medicine|December 20, 2023
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profilesChristian Pozzorini, Gregoire Andre, Tommaso Coletta, et al.The Lancet. Haematology|November 21, 2017
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot studyBerend Snijder, Gregory I Vladimer, Nikolaus Krall, et al.Cancer Discovery|October 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional RespondersChristoph Kornauth, Tea Pemovska, Gregory I Vladimer, et al.Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.Pageof 15